Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients
Loading...
Date
Authors
Mitrogianni, Z.
Barbouti, A.
Galaris, D.
Siamopoulos, K. C.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
Nephron Clin Pract
Book name
Book series
Book edition
Alternative title / Subtitle
Description
BACKGROUND/AIMS: Oxidative damage has been reported to be involved in the pathophysiology of chronic kidney disease (CKD) as well as in the pathogenesis of cardiovascular complications of CKD patients. The aim of the present investigation was to evaluate the levels of plasma carbonyl formation, a sensitive marker of enhanced oxidative stress in predialysis, hemodialysis (HD) and peritoneal dialysis (PD) patients. METHODS: Plasma samples from 20 apparently healthy control individuals and 127 CKD (stages 2, 3, 4, HD and PD) patients were evaluated by Western blot analysis for the estimation of the levels of protein carbonyl formation. RESULTS: Albumin represented the main plasma carbonylated protein. Increasing carbonylation of albumin was detected along with the severity of CKD, reaching significance at stages 3 and 4 (p < 0.01, compared to healthy controls). The carbonylation of albumin was even higher in the plasma of HD patients (p < 0.001), while in PD patients it was not statistically significant compared to controls (p = 0.224). CONCLUSIONS: The data presented in this work indicate that oxidative stress in CKD patients gradually increased during the development of the disease. This stress is probably intensified during HD, but not in PD subjects.
Description
Keywords
Adolescent, Adult, Aged, Aged, 80 and over, Albumins/*metabolism, Biological Markers/blood, Female, Humans, Kidney Failure, Chronic/*blood/diagnosis, Male, Middle Aged, Oxidation-Reduction, Oxidative Stress/*physiology, *Peritoneal Dialysis/adverse effects, Protein Carbonylation/physiology, *Renal Dialysis/adverse effects, Young Adult
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/19690441
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=000235244&Ausgabe=250406&ProduktNr=228539&filename=000235244.pdf
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=000235244&Ausgabe=250406&ProduktNr=228539&filename=000235244.pdf
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής